Delisting risk
Nano-X Imaging (NNOX)
Develops Nanox.ARC imaging systems, AI tools, radiology services, and health IT.
$0.7753
Pre-market+0.01 (+1.53%)
At close$0.7636(−2.84%)
In millions of USD, except per-share figures
| In millions | Q2 FY23Jun 2023 | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
| Cost of revenue | 4 | 4 | 4 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 |
| Gross profit | −2 | −2 | −2 | −2 | −3 | −3 | −3 | −3 | −3 | −3 | −4 | −3 |
| 16 | 13 | 12 | 11 | 11 | 11 | 12 | 11 | 11 | 11 | 14 | 12 | |
| Research & development | 7 | 6 | 7 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 0 |
| 8 | 6 | 5 | 6 | 7 | 7 | 7 | 6 | 6 | 7 | 8 | 7 | |
| Selling & marketing | 1 | 1 | −1 | 1 | 1 | 1 | −1 | 1 | 1 | 1 | −1 | 2 |
| General & administrative | 8 | 5 | 6 | 5 | 6 | 6 | 7 | 5 | 5 | 5 | 9 | 5 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 5 |
| Operating income | −18 | −22 | −13 | −13 | −15 | −14 | −15 | −14 | −14 | −14 | −18 | −15 |
| 0 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | −17 | 1 | |
| Interest income | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | −7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | −17 | −21 | −10 | −12 | −14 | −14 | −14 | −13 | −15 | −14 | −35 | −14 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −2 | 0 |
| Net income from continuing operations | −17 | −21 | −10 | −12 | −14 | −14 | −14 | −13 | −15 | −14 | −33 | −14 |
| Net income | −17 | −21 | −10 | −12 | −14 | −14 | −14 | −13 | −15 | −14 | −33 | −14 |
| EPS, basic | −$0.31 | −$0.37 | −$0.18 | −$0.21 | −$0.23 | −$0.23 | −$0.23 | −$0.21 | −$0.23 | −$0.21 | −$0.50 | −$0.20 |
| EPS, diluted | −$0.31 | −$0.37 | −$0.18 | −$0.21 | −$0.23 | −$0.23 | −$0.23 | −$0.21 | −$0.23 | −$0.21 | −$0.50 | −$0.20 |
| Weighted average shares, basic | 55 | 57 | 58 | 58 | 58 | 59 | 60 | 64 | 64 | 64 | 67 | 70 |
| Weighted average shares, diluted | 55 | 57 | 58 | 58 | 58 | 59 | 60 | 64 | 64 | 64 | 67 | 70 |
| EBITDA | −15 | −12 | −8 | −10 | −12 | −11 | −11 | −11 | −12 | −11 | −15 | −12 |
| Depreciation & amortization | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| EBIT | −18 | −15 | −11 | −13 | −15 | −14 | −14 | −14 | −14 | −14 | −18 | −15 |
